Bluestar Adisseo Company (SHA:600299)

China · Delayed Price · Currency is CNY

13.80

-0.38 (-2.68%)

Apr 28, 2026, 3:00 PM CST

40.82% (1Y)

Market Cap	42.50B
Revenue (ttm)	17.23B
Net Income (ttm)	1.15B
Shares Out	3.08B
EPS (ttm)	0.43
PE Ratio	32.12
Forward PE	30.67
Dividend	0.15 (1.06%)
Ex-Dividend Date	Feb 27, 2026

Volume	16,144,176
Average Volume	25,878,170
Open	14.17
Previous Close	14.18
Day's Range	13.40 - 14.19
52-Week Range	8.66 - 16.48
Beta	0.43
RSI	50.01
Earnings Date	Apr 30, 2026

About Bluestar Adisseo Company

Bluestar Adisseo Company, together with its subsidiaries, engages in the research, development, production, and sale of poultry, ruminant, swine, and aquaculture nutrition additives. The company also offers mycotoxin management and palatability comprising, Unike Plus, Unike, Oxy-Nil, Mold-Nil, Salmo-Nil, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, Delistart, Pepsea, Nutri-Bind Aqua, and Oxy-Nil Aqua Zero; enzymes and emulsifiers, including Rhodimet AT88 and Rhodimet; antioxidants and health by nutrition products, comprising Rhodimet AT... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 1939

Employees 3,295

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600299

Full Company Profile

Financial Performance

In 2025, Bluestar Adisseo Company's revenue was 17.23 billion, an increase of 10.92% compared to the previous year's 15.53 billion. Earnings were 1.15 billion, a decrease of -4.13%.

Financial Statements

News

There is no news available yet.